Position in SRRK
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$6,620,020
-$4,345,806 QoQ
Shares Held
120,364
-46.0% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#82
of 304 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. SRRK ranks #36 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in SRRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,620,020 | 120,364 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $10,965,826 | 223,064 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $12,397,608 | 281,444 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $11,633,701 | 312,398 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $11,817,032 | 333,626 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $10,899,364 | 339,016 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $15,680,648 | 362,810 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,189,453 | 273,340 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $2,579,351 | 309,646 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $5,499,312 | 309,646 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $6,390,007 | 339,894 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,387,687 | 336,294 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,846,719 | 244,923 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,906,584 | 238,323 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,156,823 | 238,323 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,542,299 | 222,554 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $779,497 | 141,985 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,865,737 | 144,743 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,700,265 | 148,964 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,816,154 | 115,571 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,967,191 | 102,671 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $5,389,970 | 106,395 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,444,134 | 91,575 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $783,224 | 44,275 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $408,177 | 22,415 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $271,445 | 22,415 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||